Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation

Molecular Cancer Research

Volumn 12, Issue 7, 2014, Pages 1002-1015

  Palayoor, Sanjeewani T ^a   John Aryankalayil, Molykutty ^a   Makinde, Adeola Y ^a   Falduto, Michael T ^b   Magnuson, Scott R ^b   Coleman, C Norman ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GenUs BioSystems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DATA ANALYSIS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; IMMUNE RESPONSE GENE; MICROARRAY ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOTHERAPY; REGULATOR GENE; RNA TRANSCRIPTION; STRESS; TUMOR MICROENVIRONMENT; BIOSYNTHESIS; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGICAL STRESS; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE;

APOPTOSIS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; STRESS, PHYSIOLOGICAL;

EID: 84904258204     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0623     Document Type: Article

References (48)

1. Demaria S, Formenti SC. Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front Oncol 2012;2:153.
2. Withers HR. Biologic basis for altered fractionation schemes. Cancer 1985;55:2086-95. (Pubitemid 15077682)
3. Pedraza Muriel V. Hypofractionation in radiotherapy. Clin Transl Oncol 2007;9:21-7.
4. Wang X, Hu C, Eisbruch A. Organ-sparing radiation therapy for head and neck cancer. Nat Rev Clin Oncol 2011;8:639-48.
5. Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys 2012;83:1306-10.
6. Makinde AY, John-Aryankalayil M, Palayoor ST, Cerna D, Coleman CN. Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy. Mol Cancer Res 2013;11:5-12.
7. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 2006;6:702-13. (Pubitemid 44286002)
8. Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S, et al. Gene expression pro filing of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 2007;67:3845-52. (Pubitemid 46762172)
9. John-Aryankalayil M, Palayoor ST, Cerna D, Simone CBII, Falduto MT, Magnuson SR, et al. Fractionated radiation therapy can induce a molecular profile for therapeutic targeting. Radiat Res 2010;174:446-58.
10. Simone CB II, John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Falduto MT, et al. mRNA expression profiles for prostate cancer following fractionated irradiation are in fluenced by p53 status. Transl Oncol 2013;6:573-85.
11. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004;5:396-400. (Pubitemid 38529411)
12. John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Simone CB II, Falduto MT, et al. Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res 2012;178:105-17.
13. Palayoor ST, John-Aryankalayil M, Makinde AY, Cerna D, Falduto MT, Magnuson SR, et al. Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects. J Cardiovasc Pharmacol 2012;59:487-99.
14. Hu H, Gatti RA. MicroRNAs: new players in the DNA damage response. J Mol Cell Biol 2011;3:151-8.
15. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008;9:402-12. (Pubitemid 351574202)
16. Derheimer FA, Kastan MB. Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Lett 2010;584:3675-81.
17. Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 2012;12:68-78.
18. Sonoda E, Hochegger H, Saberi A, Taniguchi Y, Takeda S. Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair 2006;5:1021-9. (Pubitemid 44291617)
19. Lohr K, Moritz C, Contente A, Dobbelstein M. p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 2003;278:32507-16. (Pubitemid 37055688)
20. Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 2003;13:49-58. (Pubitemid 36269180)
21. Powell SN, Bindra RS. Targeting the DNA damage response for cancer therapy. DNA Repair 2009;8:1153-65.
22. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation ofmiR-34a contributes to p53-mediated apoptosis. Mol Cell 2007;26:731-43. (Pubitemid 46856247)
23. Yang Y, Wu J, Guan H, Cai J, Fang L, Li J, et al. MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. FEBS Lett 2012;586:3608-12.
24. Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, Schmittgen T, et al. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci 2009;29:15161-8.
25. Nohata N, Hanazawa T, Kinoshita T, Inamine A, Kikkawa N, Itesako T, et al. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. Br J Cancer 2013;108:1648-58.
26. Jude JA, Dileepan M, Subramanian S, Solway J, Panettieri RA Jr, Walseth TF, et al. miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2012;303:L460-8.
27. Nagel S, Venturini L, Przybylski GK, Grabarczyk P, Schmidt CA, Meyer C, et al. Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymphoma 2009;50:101-8.
28. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005;102:13944-9. (Pubitemid 41377683)
29. Meisgen F, Xu N, Wei T, Janson PC, Obad S, Broom O, et al. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol 2012;21:312-4.
30. Li DQ, Pakala SB, Reddy SD, Ohshiro K, Peng SH, Lian Y, et al. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J Biol Chem 2010;285:10044-52.
31. Stewart FA, Hoving S, Russell NS. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res 2010;174:865-9.
32. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013;105:256-65.
33. Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 2006;203:1259-71. (Pubitemid 43736595)
34. Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, Lord EM. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. J Immunol 2008;180:3132-9.
35. Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, Cameron TO, et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 2008;181:3099-107.
36. Levy A, Chargari C, Cheminant M, Simon N, Bourgier C, Deutsch E. Radiation therapy and immunotherapy: implications for a combined cancer treatment. Crit Rev Oncol Hematol 2013;85:278-87.
37. Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009;15:5379-88.
38. Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res 2004;64:4328-37. (Pubitemid 38802440)
39. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012;30:295-312.
40. Westbury CB, Yarnold JR. Radiation fibrosis-current clinical and therapeutic perspectives. Clin Oncol (R Coll Radiol) 2012;24:657-72.
41. Meulmeester E, Ten Dijke P. The dynamic roles of TGF-beta in cancer. J Pathol 2011;223:205-18.
42. Border WA, Noble NA. Transforming growth factor beta in tissue fi brosis. N Engl J Med 1994;331:1286-92. (Pubitemid 24333194)
43. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008;105:13027-32.
44. Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway. Circulation 2012;126:840-50.
45. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-4.
46. Coleman CN. Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it's time to get together again!). Radiology 2003;228:29-35. (Pubitemid 36736066)
47. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
48. Bussolati B, Deregibus MC, Camussi G. Characterization of molecular and functional alterations of tumor endothelial cells to design antiangiogenic strategies. Curr Vasc Pharmacol 2010;8:220-32.